Search results
Biotech Stock Roundup: GSK's Litigation Update, BIIB's Drug Approval & Other Updates
Zacks via Yahoo Finance· 11 hours agoThis study evaluated four different doses of VK2809 — 1 mg, 2.5 mg, 5 mg and 10mg. Results showed...
EU health watchdog issues STI warning ahead of summer festival season
The Telegraph via Yahoo News· 13 hours agoExperts have warned the number of sexually transmitted infections (STIs) will skyrocket in Europe...
Tattoos may increase blood cancer risk by 21%
MedicalNewsToday via AOL· 7 days agoResearch from Sweden has found a link between getting a tattoo of any size and an overall 21% higher risk of developing lymphoma, a type of blood cancer.
The 5 Biggest Early Warning Signs Of Liver Damage
HuffPost Life via Yahoo News· 2 days agoDouglas Weine, a gastroenterologist at Hackensack Meridian Health Center. Liver conditions include non-alcoholic fatty liver disease, hepatitis or even...
We must remember the heroes of the AIDS epidemic, not just the trauma
LA Times via Yahoo News· 18 hours agoAt the time, rates of hepatitis B were higher among gay men, so the Castro became a hub for...
Magistrate Sides With Defendants in Inmate's Claims in Failure to Treat Hep C | Law.com
Law.com· 4 days agoIn a memorandum opinion and recommendation issued May 28, Auld found that physician assistant Karen...
Get regular blood tests and screening if you have multiple sex partners
Rolling Out· 5 days agoIf you have regular sex partners, getting regular STD testing is an essential part of maintaining...
Is It Safe to Breastfeed If There Is Blood In Breast Milk?
Parents via Yahoo News· 2 days agoUnderstand what conditions might cause blood to appear in breastmilk, and if it's safe to continue...
Fatty Liver to Cirrhosis Timeline: Prevalence, Treatment, and Outlook
Healthline· 6 days agoIt usually takes years for fatty liver disease to progress to cirrhosis, but several factors affect...
TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024...
Morningstar· 7 days agoTG Therapeutics, Inc. (NASDAQ: TGTX), today announced presentations highlighting study designs for post-marketing studies being undertaken for BRIUMVI® (ublituximab-xiiy) in patients with relapsing ...
